NEW RESEARCHGLP-1
Orforglipron, a new pill-form GLP-1 drug, performed better than oral semaglutide in clinical trials for blood sugar control and weight loss. However, the medication may cause more side effects than current options, and it’s easier to manufacture and store than existing treatments.